Home Monitoring for Atrial Fibrillation Using a Microlife Blood Pressure Monitor

This study assess the accuracy of a blood pressure monitor designed to detect atrial fibrillation. Subjects use the blood pressure monitor on a daily basis for 30 days and compare the readings to an ECG done at the same time.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

21 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Joseph Wiesel, MD medical office

Flushing, New York, 11355, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

any of the following

age 65 or older
hypertension
diabetes mellitus
congestive heart failure
previous stroke

Exclusion criteria

permanent pacemaker
impalantable defibrillator

Treatment and study plan

Microlife blood pressure monitor with AF detection (Microlife AFIB MLU3MQ1)

Device

Monitoring heart rhythm daily for 30 days using the blood pressure monitor and the ECG recorder.

Other names: Microlife AFIB MLU3MQ1

Primary outcomes

Sensitivity and specificity of the blood pressure monitor used for detecting atrial fibrillation compared to the electrocardiogram.

Time frame: After final subject data is available.

Secondary outcomes

Assess subjects understanding of the use of the device for atrial fibrillation.

Time frame: After final subject data is available.

Sponsors and collaborators

Lead sponsor

Microlife

Industry

Registry information

Official study title

Home Monitoring for Atrial Fibrillation Using a Microlife Blood Pressure Monitor: Trial of Regular vs Irregualr Pulse for the Prevention of Stroke (TRIPPS 2.0)

Acronym: TRIPPS

Important dates

Study start: 2009
Primary completion: 2009
Study completion: 2009
First posted: Mar 13, 2009
Registry last updated: Jan 8, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed